Indies Pharma Jamaica Limited (JMSE:INDIES)

Market Cap	3.77B -32.0%
Revenue (ttm)	1.10B -7.5%
Net Income	127.86M -43.8%
EPS	0.10 -43.6%
Shares Out	1.33B
PE Ratio	29.51
Forward PE	n/a
Dividend	0.14 (4.77%)
Ex-Dividend Date	Apr 9, 2026

Volume	9,883
Open	n/a
Previous Close	2.830
Day's Range	2.700 - 2.830
52-Week Range	2.330 - 3.400
Beta	0.08
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 8, 2026

About Indies Pharma Jamaica

Indies Pharma Jamaica Limited engages in the distribution and retail of pharmaceutical and auxiliary products in Jamaica. It also distributes and sells beverages brand, dental products, and herbal supplements; cardiovascular, anti-hypertensive, circulation and anti-thrombotic, anti-cholesterol, gastro-intestinal, anti-diabetes, dermatology, antifungal, dermatology and anti-acne, NSAIDS and antipyretic, neurological, anti-psychiatry, oncological, anesthesiology, and nephrology agents; and venous circulation and hemorrhoids, antibiotics oral, ant...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2003
• Employees: 64
• Stock Exchange: Jamaica Stock Exchange
• Ticker Symbol: INDIES

Financial Performance

In fiscal year 2025, Indies Pharma Jamaica's revenue was 1.13 billion, a decrease of -2.82% compared to the previous year's 1.16 billion. Earnings were 181.29 million, a decrease of -18.04%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 6, 2026

Data Sources Report a data error